Hospira introduces Imipenem-Cilastatin for Injection, IV in US
Imipenem-cilastatin, a generic version of Merck’s Primaxin is a carbapenem that belongs to the beta-lactam class of antibiotics. The medication will be made available in 250 mg and
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.